ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,842.91
0.11%
Dow Jones
42,518.28
0.52%
US Dollar vs MXN
20.47969
-0.18%
Brent Oil
79.64
-0.08%
Bitcoin
96,504.59
0.00%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSX

  6. Satellos Bioscience Inc (MSCL) Cotización

Satellos Bioscience Inc

Satellos Bioscience Inc (MSCL)

Satellos Bioscience Inc
0.82
0.00
(0.00%)
Cerrado 15 Enero 3:12PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
0.82
Postura de Compra
0.81
Postura de Venta
0.83
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.38 Rango de 52 semanas 1.32
Capitalización de Mercado [m]
92.489M
Precio Anterior
0.82
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
149,847
Acciones en circulación
112,792,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-5.82
Beneficio por acción (BPA)
-0.14
turnover
-
Beneficio neto
-15.89M

Acerca de Satellos Bioscience Inc

Sector
Coml Physical, Biologcl Resh
Industria
Pharmaceutical Preparations
Sitio web
www.satellos.com
Sede
Toronto, Ontario, Can
Fundado
2007
Satellos Bioscience Inc is listed in the Coml Physical, Biologcl Resh sector of the Toronto Stock Exchange with ticker MSCL. The last closing price for Satellos Bioscience was $0.82. Over the last year, Satellos Bioscience shares have traded in a share price range of $ 0.38 to $ 1.32.

Satellos Bioscience currently has 112,792,000 shares in issue. The market capitalisation of Satellos Bioscience is $92.49 million. Satellos Bioscience has a price to earnings ratio (PE ratio) of -5.82.

MSCL Últimas noticias

Más noticias

Satellos Announces First Participant with Duchenne Muscular Dystrophy Dosed in the Phase 1b Clinical Trial of SAT-3247

- Marks successful completion of full enrollment of SAD cohorts and the first two MAD cohorts in the healthy volunteer study - Up to 10 adult participants with genetically confirmed Duchenne...

11 Diciembre 2024
Business Wire

Satellos to Participate in Oppenheimer Movers in Rare Disease Summit

Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) (“Satellos”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and...

03 Diciembre 2024
Business Wire

Satellos to Participate in Duchenne KOL Investor Webinar on December 4, 2024

Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

02 Diciembre 2024
Business Wire

Satellos Appoints Stephanie Brown to Board of Directors

Satellos Bioscience Inc. (TSX: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

14 Noviembre 2024
Business Wire

Satellos Reports Q3 2024 Financial Results and Provides Clinical Update

- Completed enrollment for SAT-3247 in Duchenne muscular dystrophy (DMD) in the first three (of five) single-ascending dose (SAD) cohorts with no safety concerns and initiated enrollment of first...

13 Noviembre 2024
Business Wire

Satellos to Participate in November 2024 Investor Conferences

Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

04 Noviembre 2024
Business Wire

Satellos Demonstrates Treatment of DMD Canines with SAT-3247 Improved Measures of Strength to Near Normal Levels

- Analysis showed improvement in muscle morphology and increased levels of regeneration in muscle groups, including the diaphragm, quadriceps, and calf - No adverse events and no significant...

01 Octubre 2024
Business Wire

Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247

- The first healthy volunteer has been dosed in the first component of the Phase 1 study - Initial safety and pharmacokinetic data expected in Q4 2024 - Initiation of the second component of...

18 Septiembre 2024
Business Wire

Satellos Announces Participation in September 2024 Investor Conferences

Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

05 Septiembre 2024
Business Wire

Satellos Announces Acceptance of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247

Dosing of first participant in a Phase 1 clinical trial of SAT-3247 anticipated in Q3 2024 Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech...

19 Agosto 2024
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.05-5.747126436780.870.880.82395590.84124123CS
4-0.1-10.86956521740.920.920.811332730.86441767CS
120.0810.81081081080.741.320.671498470.87846371CS
260.3574.46808510640.471.320.451128090.76499314CS
520.232.25806451610.621.320.38916430.69372085CS
1560.232.25806451610.621.320.38916430.69372085CS
2600.232.25806451610.621.320.38916430.69372085CS

MSCL - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Satellos Bioscience?
El precio actual de las acciones de Satellos Bioscience es $ 0.82
¿Cuántas acciones de Satellos Bioscience están en circulación?
Satellos Bioscience tiene 112,792,000 acciones en circulación
¿Cuál es la capitalización de mercado de Satellos Bioscience?
La capitalización de mercado de Satellos Bioscience es CAD 92.49M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Satellos Bioscience?
Satellos Bioscience ha negociado en un rango de $ 0.38 a $ 1.32 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Satellos Bioscience?
El ratio precio/beneficio de Satellos Bioscience es -5.82
¿Cuál es la moneda de reporte de Satellos Bioscience?
Satellos Bioscience presenta sus resultados financieros en CAD
¿Cuál es el último beneficio anual de Satellos Bioscience?
El último beneficio anual de Satellos Bioscience es CAD -15.89M
¿Cuál es la dirección registrada de Satellos Bioscience?
La dirección registrada de Satellos Bioscience es 79 WELLINGTON STREET WEST, 33RD FLOOR, TORONTO, ONTARIO, M5K 1N2
¿Cuál es la dirección del sitio web de Satellos Bioscience?
La dirección del sitio web de Satellos Bioscience es www.satellos.com
¿En qué sector industrial opera Satellos Bioscience?
Satellos Bioscience opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
134AUPraise Inc
 0.00
(0.00%)
0
1332Nissui Corporation
 0.00
(0.00%)
0
132AIN Holdings Co Ltd
 0.00
(0.00%)
0
131ACCN Group Corp
 0.00
(0.00%)
0
130AVeritas In Silico Inc
 0.00
(0.00%)
0
134AUPraise Inc
 0.00
(0.00%)
0
1332Nissui Corporation
 0.00
(0.00%)
0
132AIN Holdings Co Ltd
 0.00
(0.00%)
0
131ACCN Group Corp
 0.00
(0.00%)
0
130AVeritas In Silico Inc
 0.00
(0.00%)
0
134AUPraise Inc
 0.00
(0.00%)
0
1332Nissui Corporation
 0.00
(0.00%)
0
132AIN Holdings Co Ltd
 0.00
(0.00%)
0
131ACCN Group Corp
 0.00
(0.00%)
0
130AVeritas In Silico Inc
 0.00
(0.00%)
0

Discusión

Ver feed completo
Invest-in-America Invest-in-America 3 minutos hace
CRWS: Movin'-on-up, to the East Side .... !!!
CRWS
saj saj 4 minutos hace
WNW joined you at .69 not sure why it's still sinking don't see any fresh news...hope it's not a delayed offering
Babubd Babubd 4 minutos hace
EPIC MOVE COMING!! 🚀🚀🚀🚀🚀🚀
TRII
tw0122 tw0122 4 minutos hace
Ignite this e-bike robot lithium battery low floater one more time at .61 cents with a 2m float. Needs some volume then back to $1s
EZGO
gp22 gp22 5 minutos hace
.$MITQ: Moving IMage Tech.: Last of the sub $1.00 "Computer Equipment" sector stocks. Volume & interest rising. Easy tech crowd target. Like the others they will likely will come for $MITQ all at once.
movingimagetech.com/
MITQ
stockinspector stockinspector 6 minutos hace
Scare tactics with zero evidence of a single claim! Same for 3-4 years.
It is impossible to provide evidence of a lost lawsuit because it is a lie!
Honest claims provide FACTS not innuendo. If there were facts you would provide them!
I call you out as a fraud. Prove yourself.
WDLF
jammy32 jammy32 6 minutos hace
It’s odd that we haven’t heard anything about the new capacity that they are waiting for approval on. Wonder why that it is. If it’s not ready, does this impact launch or would they just work double and triple shifts.

Would help if we for some updates from time to time.
ELTP
RIGATONI RIGATONI 6 minutos hace
~RDAR .0012

share structure remains the same...

https://investorshub.advfn.com/uimage/uploads/2025/1/15/cbadzRDAR_3.png
RDAR
RIGATONI RIGATONI 7 minutos hace
Good morning!~Rig
dennisdave dennisdave 8 minutos hace
Am I happy with the situation? No Neither am I
Flaskworks systems will be used in the facility. NWBO owns this technology
Sure great, Flaskworks systems will probably also be used in other cancer research and treatment facilities and CDMO's (such as CRL) NWBO will be cooperating with i
CDMO NWBO
Dcab Dcab 9 minutos hace
I inquired about the timetable of the launch of the Breast cancer test and they answered that all updates are controlled and available at our SEC filings. Just speculating but possibly there is a filing on the way, as I would think they need to partner with a larger Co. The last two words of the em
LUDG
Paulness Paulness 10 minutos hace
NEWS -- Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data

https://mma.prnewswire.com/media/1762876/Oncolytics_Biotech_New_Logo.jpg

New pancreatic cancer cohort moves forward w
MSI ONCY PDAC
Hi_Lo Hi_Lo 10 minutos hace
HQGE must be registered with the SEC (to get any corporate actions approved by the SEC/FINRA) through a Form S-4 (or Form 10) which HQGE can't do because it had its registration with the SEC terminated and still has missing financials from all of 2022, 2023 and the 2024 quarterly report.
HQGE
KingRichard3rd KingRichard3rd 10 minutos hace
Plug Seals Monumental Deal with Allied Green Ammonia for a Mega 3 GW Electrolyzer System

Let's open above 3 bucks today!

https://www.ir.plugpower.com/press-releases/news-details/2025/Plug-Seals-Monumental-Deal-with-Allied-Green-Ammonia-for-a-Mega-3-GW-Electrolyzer-Syste
PLUG
uranium-pinto-beans uranium-pinto-beans 10 minutos hace
🔸 $MGNI: Expands partnership with Samsung Ads for programmatic ads in Southeast Asia.

🔸 $S: Downgraded to Neutral from Buy by UBS.

🔸 U.S. Policy: New regulations planned to limit chip exports to China from TSMC, Samsung, and others.
MGNI S
uranium-pinto-beans uranium-pinto-beans 10 minutos hace
🔸 $CVGW: Q4 EPS 5c vs. -2c last year; revenue up 19.5% to $170M vs. $161.93M est.; adj EBITDA $6.7M.
🔸 $GM: Multi-year deal with Vianode for synthetic graphite for EV batteries.
🔸 $TSLA: SEC sues Elon Musk for late disclosure of Twitter stake in 2022.
ALUMINUM APLD BHLB
Monksdream Monksdream 11 minutos hace
Top15 at 7:15
https://ih.advfn.com/markets/nasdaq/premarket
Hugie Hugie 11 minutos hace
They are already one week late....
SPOM
stocktowatch stocktowatch 11 minutos hace
$CBDW News - 1606 Corp. Applauds Adnexus Biotechnologies' Launch of Trapicolast: A Revolutionary New AI-Driven Malaria Drug https://finance.yahoo.com/news/1606-corp-applauds-adnexus-biotechnologies-130000493.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
CBDW
Invest-in-America Invest-in-America 12 minutos hace
VMAR: THAT would be nice!!
VMAR
Investor2014 Investor2014 12 minutos hace
Yes VPN was the answer.
AVXL
nowwhat2 nowwhat2 14 minutos hace
https://investorshub.advfn.com/uimage/uploads/2025/1/15/erpqhxrp_!_14_6m_9pm_DUNCES__RESIST.jpg






https://investorshub.advfn.com/uimage/uploads/2025/1/15/chejpXRP_!_15_CAPT_4am_clonk_resist_cpi_ppi_summary.jpg



This
XRPUSD

Su Consulta Reciente

TSX
MSCL
Satellos Bioscience
USOTC
FRMA
Firma (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados